华大基因：前三季营收26.74亿，Q3营收增9.19%

Core Insights - BGI Genomics reported a decline in revenue and a negative net profit for the first three quarters of 2025 [1] Financial Performance - For the first three quarters, the company achieved a revenue of 2.674 billion yuan, a year-on-year decrease of 5.39% [1] - The net profit attributable to shareholders was -21.387 million yuan [1] - In the third quarter, the company generated a revenue of 1.042 billion yuan, reflecting a year-on-year growth of 9.19% [1] - However, the net profit for the third quarter was still negative at -27.1652 million yuan [1]